Ning, J.X., Ye, N., Wang, G.Q., Bian, W.J. and Cheng, H. (2024) Research Progress on Safety of Antithrombotic Therapy in Patients with Chronic Kidney Disease and Atrial Fibrillation after percutaneous Coronary Intervention. Journal of Clinical Nephrology, 24, 772-775.

has been cited by the following article:

• TITLE: Research Progress of Atrial Fibrosis in Recurrence of Atrial Fibrillation

  AUTHORS: Ke Li, Jingchao Long

  KEYWORDS: Atrial Ibrosis, Atrial Fibrillation, Recurrence, Radiofrequency Ablation

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.12, December 24, 2024

  ABSTRACT: Atrial fibrillation (AF) is the most common arrhythmia in clinic. With the increasing aging of the population in China, the incidence of atrial fibrillation is also increasing with age. The formation and progression of atrial fibrillation are mainly the changes of atrial anatomical structure and electrophysiological mechanism, in which atrial fibrosis plays a key role in the structural remodeling and electrical remodeling of atrial fibrillation. Although catheter ablation has been widely used in the basic treatment of atrial fibrillation, recurrence of atrial fibrillation may occur after radiofrequency ablation. The key factor of recurrence of atrial fibrillation is atrial fibrosis, so early intervention measures for early diagnosis and treatment of atrial fibrosis are helpful to reduce the recurrence rate after radiofrequency ablation. This article will comprehensively summarize the relevant studies of recurrence of atrial fibrosis after radiofrequency ablation of atrial fibrillation, in order to seek the treatment of recurrence after radiofrequency ablation of atrial fibrillation.